ProShare Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,750
| Closed | -$155K | – | 1999 |
|
|
2025
Q4 | $155K | Buy |
+10,750
| New | +$134K | ﹤0.01% | 1789 |
|
|
2025
Q3 | – | Sell |
-11,468
| Closed | -$94.2K | – | 2093 |
|
|
2025
Q2 | $94.2K | Sell |
11,468
-835
| -7% | -$6.99K | ﹤0.01% | 1889 |
|
|
2025
Q1 | $88K | Sell |
12,303
-3,011
| -20% | -$22.4K | ﹤0.01% | 1866 |
|
|
2024
Q4 | $118K | Buy |
15,314
+2,800
| +22% | +$26.3K | ﹤0.01% | 2039 |
|
|
2024
Q3 | $131K | Buy |
+12,514
| New | +$153K | ﹤0.01% | 1839 |
|
|
2024
Q2 | – | Sell |
-11,384
| Closed | -$240K | – | 1970 |
|
|
2024
Q1 | $240K | Buy |
11,384
+874
| +8% | +$15.6K | ﹤0.01% | 1565 |
|
|
2023
Q4 | $189K | Buy |
+10,510
| New | +$185K | ﹤0.01% | 1653 |
|
|
2023
Q1 | – | Sell |
-9,847
| Closed | -$223K | – | 1888 |
|
|
2022
Q4 | $223K | Buy |
9,847
+758
| +8% | +$17.1K | ﹤0.01% | 1418 |
|
|
2022
Q3 | $240K | Buy |
9,089
+129
| +1% | +$3.83K | ﹤0.01% | 1283 |
|
|
2022
Q2 | $221K | Sell |
8,960
-4,177
| -32% | -$104K | ﹤0.01% | 1408 |
|
|
2022
Q1 | $436K | Sell |
13,137
-2,691
| -17% | -$74.8K | ﹤0.01% | 1370 |
|
|
2021
Q4 | $518K | Buy |
15,828
+703
| +5% | +$23.9K | ﹤0.01% | 1414 |
|
|
2021
Q3 | $634K | Sell |
15,125
-3,699
| -20% | -$133K | ﹤0.01% | 1073 |
|
|
2021
Q2 | $731K | Buy |
18,824
+1,602
| +9% | +$57.3K | ﹤0.01% | 1246 |
|
|
2021
Q1 | $587K | Buy |
17,222
+3,334
| +24% | +$142K | ﹤0.01% | 1329 |
|
|
2020
Q4 | $630K | Buy |
13,888
+3,158
| +29% | +$110K | ﹤0.01% | 1128 |
|
|
2020
Q3 | $295K | Sell |
10,730
-380
| -3% | -$12.4K | ﹤0.01% | 1189 |
|
|
2020
Q2 | $409K | Buy |
11,110
+3,570
| +47% | +$133K | ﹤0.01% | 1055 |
|
|
2020
Q1 | $244K | Sell |
7,540
-5,818
| -44% | -$242K | ﹤0.01% | 939 |
|
|
2019
Q4 | $547K | Sell |
13,358
-1,200
| -8% | -$47.4K | ﹤0.01% | 1023 |
|
|
2019
Q3 | $518K | Sell |
14,558
-411
| -3% | -$16.7K | ﹤0.01% | 971 |
|
|
2019
Q2 | $769K | Sell |
14,969
-1,770
| -11% | -$88.4K | ﹤0.01% | 859 |
|
|
2019
Q1 | $959K | Buy |
16,739
+366
| +2% | +$18.1K | 0.01% | 778 |
|
|
2018
Q4 | $687K | Sell |
16,373
-2,684
| -14% | -$157K | ﹤0.01% | 828 |
|
|
2018
Q3 | $1.44M | Buy |
19,057
+1,005
| +6% | +$72.4K | 0.01% | 681 |
|
|
2018
Q2 | $1.29M | Buy |
18,052
+95
| +0.5% | +$4.54K | 0.01% | 743 |
|
|
2018
Q1 | $536K | Sell |
17,957
-2,908
| -14% | -$84.6K | ﹤0.01% | 1068 |
|
|
2017
Q4 | $694K | Buy |
20,865
+1,572
| +8% | +$47.4K | ﹤0.01% | 983 |
|
|
2017
Q3 | $636K | Buy |
19,293
+1,041
| +6% | +$23.4K | 0.01% | 876 |
|
|
2017
Q2 | $360K | Buy |
18,252
+1,790
| +11% | +$34.7K | ﹤0.01% | 1079 |
|
|
2017
Q1 | $318K | Sell |
16,462
-4,282
| -21% | -$82.6K | ﹤0.01% | 1213 |
|
|
2016
Q4 | $385K | Buy |
+20,744
| New | +$396K | ﹤0.01% | 1222 |
|
Other funds holding RGNX
RG
IHAM
ProShare Advisors's RGNX Position: Q1 2026 in Review
ProShare Advisors sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 10,750 shares — an estimated $155K sold.
ProShare Advisors first reported a position in RGNX in Q4 2016 and held it in 32 quarters. The position peaked at $1.44M in Q3 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- ProShare Advisors reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
- ProShare Advisors sold 10,750 Regenxbio shares in Q1 2026, an estimated $155K.
- ProShare Advisors first reported a position in Regenxbio in Q4 2016 and held it in 32 quarters.
- ProShare Advisors's Regenxbio position peaked at $1.44M in Q3 2018.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.